Rezolute Announces Uplisting to the Nasdaq Capital Market
November 05, 2020 08:00 ET
|
Rezolute Inc.
REDWOOD CITY, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (OCTQB:RZLTD), a clinical stage biopharmaceutical company dedicated to advancing therapies for rare, metabolic and...
Rezolute Announces $41 Million Private Placement with Leading Investment Firms and Prepares to Imminently Up-list to Nasdaq
October 09, 2020 08:30 ET
|
Rezolute Inc.
REDWOOD CITY, Calif., Oct. 09, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (OCTQB:RZLT), a clinical stage biopharmaceutical company dedicated to advancing therapies for rare, metabolic, and...
Rezolute, Inc. Welcomes Pharmaceutical Industry Leader Philippe Fauchet to its Board of Directors
September 10, 2020 08:00 ET
|
Rezolute Inc.
REDWOOD CITY, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (OTCQB:RZLT), announced today that the Company has appointed veteran global healthcare executive...